Giordano achieved a Master's degree in Medical Biotechnology and Bioengineering at Sapienza Università di Roma in 2017, obtaining the acknowledgement as excellent graduate. Driven by a strong interest for research, he did his PhD in Neuroscience at Università Cattolica del Sacro Cuore. During this timespan, he focused on the use of graphene quantum dots as anticancer sensitizing agents against the most lethal and aggressive brain tumor, glioblastoma. His dedication and commitment were evident as he completed this program in 2021. Giordano's professional journey continued with a transition into the role of Research Fellow at Università Cattolica del Sacro Cuore in Rome, starting from March 2021. He explored the use of other biocompatible materials in the field of oncology, moving from nanomedicine towards 3D-biopriunting. His academic and research journey has been complemented by awards and achievements, including the AIRC – Fellowship for Italy, which he successfully secured in 2021. More recently, he has assumed the role of Researcher (RTDA) from October 2022 onwards. His research on 3D-bioprinting to reliably mimic tumor microenvironment allowed him to obtain a Prin project funding in 2023, aimed at reproducing the interface between the bloodstream and the brain to treat brain cancer.